olopatadine intranasal/mometasone, intranasal (Pending FDA Approval)

Brand and Other Names:Ryaltris
  • Print

Dosing & Uses

Allergic Rhinitis

New intranasal fixed-dose combination product pending FDA approval for allergic rhinitis

Next:

Pharmacology

Mechanism of Action

Olopatadine: Antihistamine (H1 antagonist); inhibits release of histamine from mast cells

Mometasone: Corticosteroid with potent anti-inflammatory properties; elicits effects on various cells, including mast cells and eosinophils; also elicits effects on inflammatory mediators (eg, histamine, eicosanoids, leukotrienes, cytokines)

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.